Long term use of lithium and factors associated with treatment response among patients with bipolar disorder

Psychiatria Danubina

Volumn 28, Issue 2, 2016, Pages 146-153

  Shan, Gan Wei ^a   Makmor Bakry, Mohd ^a   Omar, Marhanis Salihah ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Bipolar disorder; Lithium; Predominant depressive mood episode; Relapse rate; Response

Indexed keywords

LITHIUM; LITHIUM DERIVATIVE;

ADULT; ARTICLE; BIPOLAR DISORDER; BONE DISEASE; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; DROWSINESS; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; ENDOCRINE DISEASE; EYE DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY DISEASE; LONG TERM CARE; MALAYSIA; MALE; METABOLIC DISORDER; MONOTHERAPY; NEUROMUSCULAR DISEASE; OUTCOME ASSESSMENT; POLYURIA; PREDICTION; PRESCRIPTION; RASH; RELAPSE; RETROSPECTIVE STUDY; SKIN DISEASE; TREMOR; UROGENITAL TRACT DISEASE; AFFECT; DEPRESSION; MIDDLE AGED; PSYCHOLOGY; PSYCHOTIC DISORDERS; RECURRENT DISEASE; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AFFECT; BIPOLAR DISORDER; DEPRESSION; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84978790886     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. APA: Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159(Suppl 4):1-50.
2. Baldessarini RJ, Tondo L, Davis P et al: Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 2006; 8:625-39.
3. Baldessarini RJ & Tondo L: Does lithium treatment still work?: evidence of stable responses over three decades. Arch Gen Psychiatry 2006; 57:187-90.
4. Bhugra D & Bhui K: Ethnic and cultural factors in psychopharmacology. Adv Psychiatr Treat 1999; 5:89-95.
5. Biel MG, Peselow E, Mulcare L et al: Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study. Bipolar Disord 2007; 9:435-42.
6. Calabrese JR, Shelton MD, Rapport DJ et al: A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 2005; 162:2152-61.
7. Chen CH, Lee CS, Lee MTM et al: Variant GADL1 and response to lithium therapy in bipolar I disorder. New England J Med 2014; 370:119-28.
8. Geddes JR, Burgess S, Hawton K et al: Long-term lithium therapy for bipolar disorder: systematic review and metaanalysis of randomized controlled trials. Am J Psychiatry 2004; 161:217-22.
9. Gershon S, Chengappaa KR, Malhi GS: Lithium specificity in bipolar illness: a classic agent for the classic disorder. Bipolar Disord 2009; 11:34-44.
10. Goldberg JF, Allen MH, Miklowitz DA et al: Suicidal ideation and pharmacotherapy among STEP-BD patients. Psychiatr Serv 2005; 56:1534-40.
11. Gore FM, Bloem PJN, Patton GC et al: Global burden of disease in young people aged 10-24 years: a systematic analysis. The Lancet 2011; 377:2093-102.
12. Kemp DE, Sylvia LG, LiTMUS Study Group et al: General Medical Burden in Bipolar Disorder: Findings from the LiTMUS Comparative Effectiveness Trial. Acta Psychiatr Scand 2014; 129:1.
13. Kulhara P, Basu D, Mattoo SK et al: Lithium prophylaxis of recurrent bipolar affective disorder: long-term outcome and its psychosocial correlates. J Affect Disord 1999; 54:87-96.
14. Laxman KE, Lovibond KS, Hassan MK: Impact of bipolar disorder in employed populations. Am J Manag Care 2008; 14:757-64.
15. MADRAC 2012: Malaysian Adverse Drug Reactions Advisory Committee adverse effect reporting form [online]. 25 May. Available from: http://portal.bpfk.gov.my/index.cfm? &menuid=34&parentid=26. [Accessed 10 November 2014].
16. Malhi GS, Tanious M, Bargh D: Safe and effective use of lithium. Aus Prescr 2013; 36:18-21.
17. Mohamed Saini S, Nik Jaafar NR, Sidi H: Serotonin transporter gene polymorphism and its association with bipolar disorder across different ethnic groups in Malaysia. Compr Psychiatry 2014; 55:76-81.
18. Paton C, Barnes TR, Shingleton-Smith A et al: Lithium in bipolar and other affective disorders: prescribing practice in the UK. J Psychopharmacol 2010; 24:1739-46.
19. Solomon DA, Leon AC, Coryell WH et al: Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry 2010; 67:339-47.
20. Tighe SK, Mahon PB, Potash, JB: Predictors of lithium response in bipolar disorder. The Adv Chronic Dis 2011; 2:209-26.
21. Tondo L, Baldessarini RJ, Floris G: Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Brit J Psychiat 2001; 178:184-90.
22. Tondo L, Baldessarini RJ, Hennen J et al: Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry 1988;155:638-45.
23. Vancampfort D, Vansteelandt K, Correll CU et al: Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators. Am J Psychiatry 2013; 170:265-74.
24. Young AY & Newhan JI: Lithium in maintenance therapy for bipolar disorder. Psychopharm 2006; 20:17-22.